DNA Certified Library of Proprietary Genetics, Flower and Concentrates Available in Colorado for First Time

LOS ANGELES, April 17, 2019 (GLOBE NEWSWIRE) -- OG DNA Genetics (“DNA” or the “Company”), a globally recognized leading cannabis brand, today announced that the Company has entered into an agreement with Good Meds to bring DNA’s award-winning team to the Colorado marketplace for the first time. The partnership will provide Colorado cannabis consumers access to the DNA brand and library of proprietary genetics, flower and concentrates at Good Meds facilities in Lakewood and Englewood, Colorado.

“Colorado was the pioneer in the legalization of cannabis in the U.S., but it has faced challenges in producing and delivering connoisseur level cannabis products to the state’s consumers,” said Charles Phillips, CEO of OG DNA Genetics. “We are excited to certify our award-winning strains to the state and by the opportunities this agreement will provide to further grow our footprint. Good Meds has a strong commitment to bringing products to market with a focus on quality, which is why we have selected them as our partner.”

As part of the partnership with Good Meds, DNA will verify and certify its award winning genetics and utilize Good Meds experienced team and commitment to quality to offer an array of products to the Colorado market, including dried flower, prerolls, vape carts, sauce, rosin, and full melt water hash. The partnership will also provide DNA access to BOSM Labs for its cutting-edge hydrocarbon extract technology as well as future research and product development.

“The cannabis industry in Colorado has evolved much differently than other markets, one example of this, we are lacking globally recognized brands. DNA will bring this,” said John Knapp, Founder and CEO of Good Meds and BOSM Labs. “Our 90,000 square foot production facility that is BOSM Labs and Good Meds is an ideal platform for DNA to begin their entrance into the first fully legal cannabis market in the world. We are absolutely thrilled about the partnership and excited to introduce their suite of top tier products into the marketplace.”

About OG DNA Genetics Inc.
DNA was rooted in Los Angeles and founded in Amsterdam in 2004 by Don Morris and Aaron Yarkoni. Over the last decade, the Company has built and curated a seasoned genetic library and developed proven standard operating procedures for genetic selection, breeding, and cultivation. In a world that is increasingly opening up to commercial cannabis activity, DNA is positioned to become the first, truly geographically-diversified company with multiple partnerships with top-licensed producers and brands that have built their companies and global presence utilizing the “Powered by DNA” model. For more information, please visit www.dnagenetics.com.

About Good Meds
Good Meds was founded in Denver, Colorado in 2009 by John Knapp. As a pioneering company in a fully regulated cannabis marketplace, Good Meds operates two retail storefronts and a 90,000 square foot cultivation and extraction facility, producing world class Medical and Adult Use products. With over 65 employees, and a leadership team with decades of combined experience operating in a highly evolving and regulated environment, Good Meds is well positioned to continue its growth trajectory worldwide. For more information, please visit GoodMeds.com

About BOSM Labs
BOSM Labs begins as a passion for high-quality cannabis concentrates and a desire to be on the cutting edge of cannabis technology. While BOSM Labs has perfected several processing methods, its initial passion was in perfecting one genre of concentrate extraction, hydrocarbon. Rich in terpenes, the result is a concentrate that can capture the essence of the cannabis plant unlike any other while producing a multi-sensory explosion that washes over the user every time. BOSM Labs is based in Denver, Colorado and cultivates and sells its own source material as well as offering toll processing services for clients across the State. For more information, please visit www.BOSMLabs.com.

For further information, please contact Rezwan Khan, Vice President, Corporate Development at Rezwan@dnagenetics.com